At Jazz, we recognize that living with a complex sleep disorder, like narcolepsy or idiopathic hypersomnia, extends far beyond the core symptoms – it profoundly impacts every facet of a person’s life, from daily functioning and cognitive well-being to their overall long-term health.
Through our research, we are determined to uncover insights that promote a more holistic understanding of these conditions, reflecting our years of collaboration with patients and the broader sleep community. We design our trials considering the real-world experiences of people living with sleep disorders and accurately reflecting the needs of the community in our objectives.
That is why we explore areas like individualized treatment, the challenging reality of night and day symptom burden and the intersection of nighttime sleep and daytime symptoms. We’re also looking into the broader health spectrum, including the impact of these conditions on cardiovascular and cardiometabolic health. These insights aren’t just scientific advancements; they represent progress toward improving overall quality of life for the patients we serve.
Advocacy partners are critical to this endeavor, providing invaluable perspectives that help ensure our research truly resonates with the lived experiences of patients. This indispensable exchange of knowledge is shaped by the dedicated work, powerful voices and shared purpose of the advocacy community, helping to guide advancements in narcolepsy and idiopathic hypersomnia. One of our valued partners, Tammy Anderson, Executive Director of Wake Up Narcolepsy, emphasizes the tangible impact of these partnerships: “Advocacy groups like ours thrive on collaboration to raise awareness and support patients. How Jazz engages with us elevates the conversation around rare sleep disorders and helps drive research that directly addresses patient needs, fostering a true sense of partnership to advance care.”
Together with our advocacy community, we strive to translate scientific discoveries into tangible improvements for patients. The data to be presented at this meeting also reflects this collaborative spirit and reinforces our efforts to ensure the work goes beyond just symptom management to ultimately empower patients and healthcare providers with the knowledge they need to elevate the standard of care for these conditions.
We believe true innovation happens when science reflects the patient experience. Our presence at SLEEP 2026 – the annual meeting of the Associated Professional Sleep Societies – is a testament to this philosophy, underpinning our decades-long dedication to advancing a comprehensive understanding of sleep disorders as we strive to bring forward solutions that address the complex landscape of these conditions. We’re committed to fostering hope and improving outcomes for patients through continued research, thoughtful partnerships and an unyielding focus on patient well-being.
